Introduction At RxE2, we are committed to partnering with independent pharmacies to unlock new opportunities in clinical trials and enhance patient care. Our Pharmacy Network Manager, Teresa Gerbig, PharmD, RPh, recently had the pleasure of speaking with Jenna Eccles, RPh, the pharmacy manager and shareholder at Wheat Ridge Professional Pharmacy in Wheat Ridge, Colorado, and…
Introduction In this interview, our Pharmacy Network Manager, Teresa Gerbig, PharmD, RPh, speaks with Bruno Tching, PharmD, RPh, an independent, family-owned pharmacy owner, to explore his experiences and perspectives on the critical role of community pharmacists. Bruno shares his insights on the importance of pharmacists in their communities, the trust they cultivate with patients, and…
For three consecutive years, RxE2 has been honored in: 2024 Best Tech Startups in North Dakota 2023 Best Tech Startups in North Dakota 2022 Best Tech Startups in North Dakota 2022 Best Tech Startups in Fargo As such, The Tech Tribune reached out to our CEO, Gerald Finken, for an interview about the origin story…
Introduction: what is a hybrid clinical trial? A hybrid clinical trial is a study design that incorporates elements of traditional in-person clinical trials with decentralized clinical trial (DCT) components. In a hybrid trial, participants may still be required to attend physical clinical sites for certain procedures. However, other study activities can be conducted remotely by…
Introduction In today’s fast-paced world, pharmacies play a vital role in granting people access to fundamental medicines and health services. There are two primary categories of pharmacies: independent community pharmacies and chain pharmacies. Despite serving as crucial healthcare facilities, they differ greatly in treating patients, offering customized services, and incorporating with the community. In this…
While RxE2 continues promoting the practice of pharmacy and community-based pharmacists in clinical trials in the United States, the European Association of Hospital Pharmacies (EAHP) is encouraging the involvement of hospital pharmacists in European clinical trials. RxE2 applauds the EAHP for taking a position on clinical trials and their recognition of the valuable contributions pharmacists…
Diversity in Clinical Trials – Background The Federal Drug Administration (FDA) issued non-compulsory guidance on clinical trial diversity to encourage diverse populations in clinical trials and improve the applicability of clinical trial results. The guidance recommends diverse clinical trial populations to better understand the safety and effectiveness of medical products across race, ethnicity, and gender.…
Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. After all, clinical trials are designed to establish the safety and efficacy of drugs: a pharmacist’s specialty. However, pharmacists are rarely consulted in clinical trials. To remedy this issue, Founder and CEO…
Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. Surprisingly, their skill sets are rarely used in clinical trials. That’s why Founder and CEO Gerald Finken created RxE2, a community-based decentralized trial technology company spearheaded by pharmacists, offering primary stakeholders their…
Welcome to our E2 Dispensing Webinar series. Over the next few weeks, we will release 8 episodes, introducing the E2 dispensing methodology and ecosystem to all. These webinars are aimed at everyone involved in clinical research and clinical trials. We will go into RxE2’s innovative and disruptive way of simplifying decentralized clinical trials and more specifically introducing…
By: Gerald E. Finken Originally posted on Linkedin In November 2021, McKinsey & Company published an interesting article on how to boost excellence and innovation in clinical supply chains that are relevant to today’s industry practices. What I found most compelling was how a best-in-class clinical supply chain could change and adapt to accommodate decentralized clinical trials (DCTs)…
By: Gerald E. Finken Originally posted on Linkedin Being a pharmacist has always given me a unique insight into healthcare, especially as my career took me into the packaging and labeling of clinical supplies. I was always able to think about the packaging and labeling of clinical supplies from a different perspective, both as a…
New drugs and treatments have to undergo a slew of studies and tests to help patients who need cures for their conditions. Clinical trials lay the foundation of efficacy and safety for new therapies and drugs. However, the process could be herculean for trial coordinators and pharmaceutical companies that dedicate a great deal of time,…
By: Gerald E. Finken The introduction of decentralized clinical trials (“DCTs”) into clinical research has, in recent years, focused on the use of technology and telehealth to improve the clinical trial experience for patients. The proponents of the DCT model have heralded it, and rightly so, with improving study recruitment, providing better patient diversity, and…
I want to make clinical trials available to everyone, everywhere by bringing the practice of pharmacy into clinical research. Believe it or not, this has never been done before. It will improve healthcare by giving people worldwide clear access to more lifesaving medicines and access to the medication experts — the pharmacist. In an interview…
